Login / Signup

An Open-Label, Randomized, Prospective, Comparative, Three-Arm Clinical Trial to Evaluate the Safety and Effectiveness of Apremilast with Three Different Titration Methods in Patients with Chronic Plaque Psoriasis in India.

Vishalakshi ViswanathPradnya JoshiPrakash LawateDakshata TareDhiraj DhootNamrata MahadkarHanmant Barkate
Published in: Psoriasis (Auckland, N.Z.) (2022)
It can be concluded that slower titration is a useful strategy for minimizing AEs while at the same time maintaining effectiveness of apremilast.
Keyphrases
  • clinical trial
  • double blind
  • randomized controlled trial
  • open label
  • systematic review
  • phase ii
  • phase iii
  • placebo controlled
  • coronary artery disease
  • study protocol
  • atopic dermatitis